BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10390604)

  • 1. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Matsuda A
    Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.
    Balzarini J; Stet L; Matsuda A; Wiebe L; Knauss E; De Clercq E
    Adv Exp Med Biol; 1998; 431():723-8. PubMed ID: 9598159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Takeda T; Sasaki T; Matsuda A; Ueda T
    J Med Chem; 1991 Feb; 34(2):778-86. PubMed ID: 1995901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
    Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
    J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
    Jashés M; González M; López-Lastra M; De Clercq E; Sandino A
    Antiviral Res; 1996 Mar; 29(2-3):309-12. PubMed ID: 8739609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.
    De Clercq E; Cools M; Balzarini J; Snoeck R; Andrei G; Hosoya M; Shigeta S; Ueda T; Minakawa N; Matsuda A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):679-84. PubMed ID: 2069373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
    Franchetti P; Cappellacci L; Sheikha GA; Jayaram HN; Gurudutt VV; Sint T; Schneider BP; Jones WD; Goldstein BM; Perra G; De Montis A; Loi AG; La Colla P; Grifantini M
    J Med Chem; 1997 May; 40(11):1731-7. PubMed ID: 9171883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN
    Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
    Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target.
    Pankiewicz KW; Patterson SE; Black PL; Jayaram HN; Risal D; Goldstein BM; Stuyver LJ; Schinazi RF
    Curr Med Chem; 2004 Apr; 11(7):887-900. PubMed ID: 15083807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.